Amicus Therapeutics
FOLD · NASDAQ
Bulios Fair Price
$9
37.9% downside
Trenutna cena
$14.49
Po podatkih Bulios Fair Price je delnica FOLD trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Amicus Therapeutics, Inc. is an American biotechnology company specializing in the development of innovative therapies for the treatment of rare genetic diseases, particularly lysosomal storage disorders. The company focuses on developing enzyme replacement therapies and other biologic treatments that can improve the health of patients suffering from diseases such as Fabry disease, Gaucher disease, and Pompe disease. Amicus Therapeutics is known for its advanced research in enzyme therapy and highly targeted treatment methods, offering new possibilities for patients for whom current treatments have been insufficiently effective.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Bradley L. Campbell
Employees
499
Headquarters
Philadelphia